Oncostress Therapeutics IVS: Financial statements 2020
CVR: 39950421
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Oncostress Therapeutics IVS (CVR 39950421) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2020 report amounted to DKK 0.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Official annual report
How creditworthy is Oncostress Therapeutics IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Oncostress Therapeutics IVS has published its interim report for the period October 17, 2018 to December 31, 2019.
About Oncostress Therapeutics IVS
Oncostress Therapeutics IVS was a Danish company of the type Iværksætterselskab based in København S, founded in 2018. The company has been dissolved on 29 September 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2020 report amounted to DKK 0.
